LIVE: Senate Finance Committee Holds Hearing on Biotechnology and the Future of Healthcare

The Senate Finance Committee holds a hearing on “Building a Resilient Health Care Future With Biotechnology” at 10 a.m. ET on Aug. 4.
Witnesses:
Alan D. Palkowitz, Ph.D., president and CEO, Indiana Biosciences Research Institute (IBRI)
Kevin Outterson, J.D., LL.M., Austin B. Fletcher professor of law and executive director and principal investigator, Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), Boston University
Vera P. Luther, M.D., M.S., section chief of infectious disease and international health, Dartmouth Hitchcock Medical Center, Dartmouth Health
Michelle Rozo, Ph.D., vice chair, National Security Commission on Emerging Biotechnology
Video Summary
AI GeneratedThis hearing examines the urgent need for the United States to reclaim global leadership in biotechnology to safeguard national security, public health, and economic stability. The discussion centers on countering China's aggressive expansion, solving the market failure surrounding antimicrobial resistance (AMR), and bridging the \"valley of death\" to translate scientific discoveries into viable medical treatments.
